Drug could be filed after “outlier” analysis.
Amgen looks to corner PCSK9 market after patent win.
Companies announce eye-catching R&D plans ahead of conference.
David Ricks revamps organisation after trial disappointment.
Six-month trial will test Babylon Health across north central London.
Prosecutors raid Athens offices, according to press reports.
Two thirds of people with asthma are not receiving basic care needed to manage their condition.
Shares rise following announcement.
Lilly/Boehringer gain further advantage in US diabetes market.